Neutrophil infiltration and myocarditis in patients with severe COVID-19: A post-mortem study
暂无分享,去创建一个
Shuyang Zhang | Y. Ping | Yaling Han | Sicong Ma | Hua-rong Zhang | Xiaohong Yao | Mian-fu Cao | X. Bian | Chengfei Peng | C. Yan | Min Luo | Y. Shi | Shuai Wang | Quan Zhang | Xiaowei Yan | Huarong Zhang
[1] J. Christie,et al. COVID-19 Critical Illness: A Data-Driven Review. , 2021, Annual review of medicine.
[2] A. Finn,et al. Response by Pellegrini et al to Letter Regarding Article, "Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study". , 2021, Circulation.
[3] L. Zentilin,et al. Correction to: SARS‑CoV‑2, myocardial injury and inflammation: insights from a large clinical and autopsy study , 2021, Clinical Research in Cardiology.
[4] M. Salomon,et al. Neutrophil-epithelial interactions augment infectivity and pro-inflammatory responses to SARS-CoV-2 infection. , 2021, bioRxiv : the preprint server for biology.
[5] L. Zentilin,et al. SARS-CoV-2, myocardial injury and inflammation: insights from a large clinical and autopsy study , 2021, Clinical Research in Cardiology.
[6] Yonggang Ma. Role of Neutrophils in Cardiac Injury and Repair Following Myocardial Infarction , 2021, Cells.
[7] X. Bian,et al. A cohort autopsy study defines COVID-19 systemic pathogenesis , 2021, Cell Research.
[8] J. Lord,et al. Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets , 2021, Frontiers in Immunology.
[9] G. Bowlin,et al. Patients with COVID-19: in the dark-NETs of neutrophils , 2021, Cell Death & Differentiation.
[10] C. Newton-Cheh,et al. Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19 , 2021, Modern Pathology.
[11] R. Virmani,et al. Pathological Evidence for SARS-CoV-2 as a Cause of Myocarditis , 2021, Journal of the American College of Cardiology.
[12] Qianghu Wang,et al. Implications of cardiac markers in risk-stratification and management for COVID-19 patients , 2020, Critical Care.
[13] Ji-Hong Liu,et al. Association of liver abnormalities with in-hospital mortality in patients with COVID-19 , 2020, Journal of Hepatology.
[14] Andrew J. Layman,et al. COVID-19–Associated Nonocclusive Fibrin Microthrombi in the Heart , 2020, Circulation.
[15] A. Mebazaa,et al. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study , 2020, Intensive Care Medicine.
[16] Yue Dong,et al. Clinical Characteristics, Treatment, and Outcomes of Critically Ill Patients With COVID-19: A Scoping Review , 2020, Mayo Clinic Proceedings.
[17] M. Halushka,et al. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations , 2020, Cardiovascular Pathology.
[18] E. Aronica,et al. Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study , 2020, The Lancet Microbe.
[19] S. Rizzo,et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study , 2020, European heart journal.
[20] P. Delvenne,et al. Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19 , 2020, The Journal of experimental medicine.
[21] P. Saldiva,et al. SARS-CoV-2–triggered neutrophil extracellular traps mediate COVID-19 pathology , 2020, The Journal of experimental medicine.
[22] M. Hémadi,et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.
[23] Yanwei Xing,et al. Cardiac injury associated with severe disease or ICU admission and death in hospitalized patients with COVID-19: a meta-analysis and systematic review , 2020, Critical Care.
[24] P. Kirchhof,et al. Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases. , 2020, JAMA cardiology.
[25] Robert A. Campbell,et al. Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome , 2020, Blood.
[26] C. Gazzaruso,et al. Impact of anti-rheumatic drugs and steroids on clinical course and prognosis of COVID-19 , 2020, Clinical Rheumatology.
[27] X. Bian. Autopsy of COVID-19 patients in China , 2020, National science review.
[28] H. Anders,et al. Neutrophils and Neutrophil Extracellular Traps Drive Necroinflammation in COVID-19 , 2020, Cells.
[29] R. V. Vander Heide,et al. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans , 2020, The Lancet Respiratory Medicine.
[30] C. Gazzaruso,et al. High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia , 2020, Clinical Rheumatology.
[31] A. Zangrillo,et al. Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study , 2020, European Journal of Internal Medicine.
[32] D. Brodie,et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.
[33] R. Gale,et al. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis , 2020, Leukemia.
[34] K. Mertz,et al. Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction , 2020, Histopathology.
[35] Xiaohu Zheng,et al. Effective treatment of severe COVID-19 patients with tocilizumab , 2020, Proceedings of the National Academy of Sciences.
[36] R. Woods,et al. Neutrophil extracellular traps in COVID-19. , 2020, JCI insight.
[37] J. M. Crawford,et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps , 2020, The Journal of experimental medicine.
[38] M. Nishimura,et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations , 2020, The Lancet Respiratory Medicine.
[39] S. Merler,et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. , 2020, JAMA.
[40] Chengliang Zhu,et al. Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China , 2020, Journal of medical virology.
[41] Yan Zhao,et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China , 2020, Clinical Immunology.
[42] W. Gong,et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.
[43] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[44] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[45] T. Phillips. Challenges and recommendations , 2019, Forests and Water.
[46] M. Delgado-Rodríguez,et al. Systematic review and meta-analysis. , 2017, Medicina intensiva.
[47] Dennis Andersson,et al. A retrospective cohort study , 2018 .
[48] Stephen H. Bell,et al. A ?scoping review. , 2018, Sexual health.
[49] S. Perlman,et al. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology , 2017, Seminars in Immunopathology.
[50] 藤倉雄二,et al. わが国における成人市中肺炎の原因微生物の変遷(Meta‐analysis and systematic review) , 2017 .
[51] Y. Lam,et al. A single centre retrospective cohort study to evaluate the association between implementation of an acute myocardial infarction clinical pathway and clinical outcomes. , 2015, International journal of cardiology.
[52] Y. Pinto,et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2014, European heart journal.
[53] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[54] B. Amulic,et al. Neutrophil extracellular traps , 2011, Current Biology.
[55] V. Preedy,et al. Prospective Cohort Study , 2010 .
[56] H. Aretz. Myocarditis: the Dallas criteria. , 1987, Human pathology.